✦ LIBER ✦

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease

✍ Scribed by Hyohun Park; Toshihide Shima; Kanji Yamaguchi; Hironori Mitsuyoshi; Masahito Minami; Kohichiroh Yasui; Yoshito Itoh; Toshikazu Yoshikawa; Michiaki Fukui; Goji Hasegawa; Naoto Nakamura; Mitsuhiro Ohta; Hiroshi Obayashi; Takeshi Okanoue

Book ID: 106180709
Publisher: Springer Japan
Year: 2010
Tongue: English
Weight: 219 KB
Volume: 46
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-010-0291-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term prognosis of nonalcoholic fatt

Long-term prognosis of nonalcoholic fatty liver disease: Is pharmacological therapy actually necessary?

✍ KUBILAY CINAR; SAHIN COBAN; RAMAZAN IDILMAN; ALI TUZUN; MUSTAFA SARIOGLU; MEHMET 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Long-term mortality in nonalcoholic fatt

Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

✍ Paul Angulo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Corrections: Long-term mortality in nona

Corrections: Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

✍ Paul Angulo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 1 views

Data describing cirrhosis prevalence in the simple steatosis group reported in the study by Rafiq et al. should read NR (not reported) instead of 42 (56.8%). All cirrhosis prevalence proportions were calculated based upon these correct (NR) data.

Increased serum FGF21 levels in patients

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

✍ Yusuf Yilmaz; Fatih Eren; Oya Yonal; Ramazan Kurt; Bilge Aktas; Cigdem Ataizi Ce 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Independent effects of physical activity

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

✍ Alexis St. George; Adrian Bauman; Amanda Johnston; Geoffrey Farrell; Tien Chey; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

Nonalcoholic fatty liver disease, characterized by elevated liver enzymes, central obesity, and insulin resistance, is becoming increasingly prevalent. The effects of changes in physical activity on the metabolic profile of this group have not been reported. We assessed at 3 months the impact of a b

Long-term efficacy of rosiglitazone in n

Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

✍ Vlad Ratziu; Fréderic Charlotte; Carole Bernhardt; Philippe Giral; Marine Halbro 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB 👁 1 views

Short-term trials of glitazones in nonalcoholic steatohepatitis (NASH) yielded controversial histological results. Longer treatment might result in additional improvement. After a 1-year randomized trial, 53 patients underwent a control liver biopsy and were enrolled in an open-label extension trial